Literature DB >> 3178868

Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells.

C K Chu1, R F Schinazi, B H Arnold, D L Cannon, B Doboszewski, V B Bhadti, Z P Gu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3178868     DOI： 10.1016/0006-2952(88)90383-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  12 in total

1.  Structure-activity relationships and mode of action of 5-mercapto-substituted oligo- and polynucleotides as antitemplates inhibiting replication of human immunodeficiency virus type 1.

Authors:  T J Bardos; R F Schinazi; K H Ling; A R Heider
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.

Authors:  R F Schinazi; J P Sommadossi; V Saalmann; D L Cannon; M Y Xie; G C Hart; G A Smith; E F Hahn
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 3.  Antiviral activities of isometric dideoxynucleosides of D- and L-related stereochemistry.

Authors:  V Nair; T S Jahnke
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

4.  Mechanism of anti-human immunodeficiency virus activity of beta-D-6-cyclopropylamino-2',3'-didehydro-2',3'-dideoxyguanosine.

Authors:  Adrian S Ray; Brenda I Hernandez-Santiago; Judy S Mathew; Eisuke Murakami; Carey Bozeman; Meng-Yu Xie; Ginger E Dutschman; Elizabeth Gullen; Zhenjun Yang; Selwyn Hurwitz; Yung-Chi Cheng; Chung K Chu; Harold McClure; Raymond F Schinazi; Karen S Anderson
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agent.

Authors:  Adrian S Ray; Zhenjun Yang; Chung K Chu; Karen S Anderson
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

6.  Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents.

Authors:  K Lee; C K Chu
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

7.  Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretrovirals.

Authors:  Walter Rangel Lopes de Campos; Dayaneethie Coopusamy; Lynn Morris; Bongani M Mayosi; Makobetsa Khati
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

Review 8.  Antiviral therapy in human immunodeficiency virus infection.

Authors:  E Sandström
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

9.  Molecular mechanics studies on the conformations of 2',3'-dideoxy-2',3'-didehydroguanine nucleoside, D4G.

Authors:  S N Rao
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

10.  Novel reporter T-cell line highly susceptible to both CCR5- and CXCR4-using human immunodeficiency virus type 1 and its application to drug susceptibility tests.

Authors:  Hiroshi Miyake; Yuji Iizawa; Masanori Baba
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.